Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07652905
What this trial is testing

CM336 Plus Isa-VR in Newly Diagnosed Primary Plasma Cell Leukemia

Who this might be right for
Plasma Cell Leukemia (PCL)
Institute of Hematology & Blood Diseases Hospital, China 24
Large-scale testing (Phase 3)Ended earlyNCT00215943
What this trial is testing

Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 90
Early research (Phase 1)UnknownNCT02955810
What this trial is testing

Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA)

Who this might be right for
Multiple Myeloma
National University of Ireland, Galway, Ireland 18
Large-scale testing (Phase 3)Active Not RecruitingNCT03617731
What this trial is testing

Trial on the Effect of Isatuximab to Lenalidomide/Bortezomib/Dexamethasone (RVd) Induction and Lenalidomide Maintenance in Patients With Newly Diagnosed Myeloma (GMMG HD7)

Who this might be right for
Multiple Myeloma
University of Heidelberg Medical Center 662
Large-scale testing (Phase 3)Study completedNCT03993912
What this trial is testing

Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy

Who this might be right for
Multiple Myeloma
University Hospital, Lille 294
Not applicableStudy completedNCT02741544
What this trial is testing

Revlimid® Capsules Special Drug Use-results Survey (in Patients With Newly-diagnosed Multiple Myeloma [NDMM])

Who this might be right for
Multiple Myeloma
Celgene 578
Testing effectiveness (Phase 2)Study completedNCT02880228
What this trial is testing

Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant

Who this might be right for
Plasma Cell Myeloma
Mayo Clinic 11
Not applicableStudy completedNCT05835726
What this trial is testing

Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients.

Who this might be right for
Multiple MyelomaDaratumumabAutologous Stem Cell Transplantation+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 188
Testing effectiveness (Phase 2)Active Not RecruitingNCT03896737
What this trial is testing

Daratumumab-bortezomib-dexamethasone (Dara-VCd) vs Bortezomib-Thalidomide-Dexamethasone (VTd), Then Maintenance With Ixazomib (IXA) or IXA-Dara

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 401
Testing effectiveness (Phase 2)UnknownNCT03942224
What this trial is testing

Daratumumab, Ixazomib, & Dexamethasone or Daratumumab, Bortezomib, & Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Plasma Cell Myeloma
Emory University 49
Not applicableLooking for participantsNCT07663253
What this trial is testing

Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Shanghai Zhongshan Hospital 333
Early research (Phase 1)WithdrawnNCT03283046
What this trial is testing

Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Malignant Neoplasms Stated as Primary Lymphoid HaematopoieticMultiple Myeloma
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT06918002
What this trial is testing

Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Intergroupe Francophone du Myelome 824
Testing effectiveness (Phase 2)Active Not RecruitingNCT04430894
What this trial is testing

KRDI in Transplant-Eligible MM

Who this might be right for
Multiple Myeloma
Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT04106700
What this trial is testing

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Who this might be right for
Venous Thromboembolism
Instituto de Investigacion Sanitaria La Fe 60
Early research (Phase 1)Not Yet RecruitingNCT06913192
What this trial is testing

Efficacy of Sequential BCMA CAR-T Cell Therapy Following Autologous Hematopoietic Stem Cell Transplantation in Transplant-eligible Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Xuzhou Medical University 50
Large-scale testing (Phase 3)WithdrawnNCT04288765
What this trial is testing

Carfilzomib, Daratumumab, Lenalidomide and Dexamethasone as First Line Treatment in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Grupo Cooperativo de Hemopatías Malignas
Large-scale testing (Phase 3)WithdrawnNCT07428369
What this trial is testing

Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM)

Who this might be right for
Multiple Myeloma (MM)
Regeneron Pharmaceuticals
Large-scale testing (Phase 3)Looking for participantsNCT06187441
What this trial is testing

FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)

Who this might be right for
Multiple Myeloma
Stichting Hemato-Oncologie voor Volwassenen Nederland 599
Testing effectiveness (Phase 2)Active Not RecruitingNCT05572229
What this trial is testing

Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Lille 74
Next Page